BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30289460)

  • 1. An Adjuvant That Increases Protective Antibody Responses to Polysaccharide Antigens and Enables Recall Responses.
    Phipps JP; Haas KM
    J Infect Dis; 2019 Jan; 219(2):323-334. PubMed ID: 30289460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
    Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.
    Chen Z; Cox KS; Tang A; Roman J; Fink M; Kaufhold RM; Guan L; Xie A; Boddicker MA; Mcguinness D; Xiao X; Li H; Skinner JM; Verch T; Retzlaff M; Vora KA
    BMC Infect Dis; 2018 Dec; 18(1):613. PubMed ID: 30509199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
    Buchanan RM; Arulanandam BP; Metzger DW
    J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
    Lefeber DJ; Benaissa-Trouw B; Vliegenthart JF; Kamerling JP; Jansen WT; Kraaijeveld K; Snippe H
    Infect Immun; 2003 Dec; 71(12):6915-20. PubMed ID: 14638780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.
    Khan AQ; Lees A; Snapper CM
    J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
    Jakobsen H; Jonsdottir I
    Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.
    Tian H; Groner A; Boes M; Pirofski LA
    Infect Immun; 2007 Apr; 75(4):1643-50. PubMed ID: 17220309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G; Chen Q; Snapper CM
    Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human memory B lymphocyte subsets fulfill distinct roles in the anti-polysaccharide and anti-protein immune response.
    Moens L; Wuyts M; Meyts I; De Boeck K; Bossuyt X
    J Immunol; 2008 Oct; 181(8):5306-12. PubMed ID: 18832686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
    Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
    Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
    Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
    J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.
    Moreno RL; Sampson JS; Romero-Steiner S; Wong B; Johnson SE; Ades E; Carlone GM
    Vaccine; 2004 Aug; 22(23-24):3069-79. PubMed ID: 15297057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7-dependent B lymphocytes are essential for the anti-polysaccharide response and protective immunity to Streptococcus pneumoniae.
    Shriner AK; Liu H; Sun G; Guimond M; Alugupalli KR
    J Immunol; 2010 Jul; 185(1):525-31. PubMed ID: 20505146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.